ALICIA MYLES: Open Payments
NPI 1023691847 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$78 in 3 payments from 3 companies in 2025. Trend: 2023 $143 · 2024 $20 · 2025 $78
Food & beverage: $78
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 1 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: NEXPLANON, INGREZZA, ENFLONSIA.
Industry payments across TX — which companies pay providers there.
